[Forced osteoarthritis therapy: expanding the scope of the possible].  The article deals the modern concepts of the mechanism of pain in osteoarthritis.
It was established that synovial inflammation and immune disorders play an important role in the pathogenesis of pain in osteoarthritis.
Hyperproduction of pro-inflammatory cytokines supports inflammation and degradation of cartilaginous tissue in osteoarthritis.
The mechanisms of pathogenetic action of chondroitin sulfate are disclosed, and the evidence base of its preclinical and clinical studies in the treatment of osteoarthritis is presented.
The data of clinical application of the Mucosat - pharmaceutical substance chondroitin sulfate in the form of a ready-made dosage form for intramuscular injection are presented.
The practical advantages of including SYSADOA in complex therapy of osteoarthritis are discussed.
